MAP3K8 Antilichaam - N-terminalgebied: FITC (ARP30650_P050-FITC)

Mitogen-activated protein kinase kinase kinase 8

COT, EST, ESTF, TPL2, AURA2, MEKK8, Tpl-2, c-COT

1326

P41279

NP_005195

Human, Mouse, Cow, Horse

The immunogen is a synthetic peptide directed towards the N terminal region of human MAP3K8

MAP3K8 is a member of the serine/threonine protein kinase family. This kinase can activate both the MAP kinase and JNK kinase pathways. This kinase was shown to activate IkappaB kinases, and thus induce the nuclear production of NF-kappaB. This kinase was

RELA; MAP2K1; RIPK1; NFKB1; ACY3; STIP1; HSP90AA1; TAB2; TRAF6; TRAF2; CD40; TNIP2; Nedd4; MAP3K14; MAP2K4; BMPR2; CHUK; REL; AKT1; NFKB2; KSR2

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity Purified

0.5 mg/ml

Cow: 75%; Horse: 87%; Human: 100%; Mouse: 85%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

53kDa

Wittwer, T. (2008) Biochem. Biophys. Res. Commun. 371 (2), 294-297

Wet Ice

467

MAP3K8

MAP3K8

Rabbit

Mitogen-activated protein kinase kinase kinase 8

NM_005204

ASEEPAVYEPSLMTMCQDSNQNDERSKSLLLSGQEVPWLSSVRYGTVEDL